Amblyopia

Abstract

Amblyopia is a reduction of vision in a structurally normal eye, caused not by any fault in the eye itself but by abnormal visual experience during a developmental critical period that reshapes the visual cortex. When the two eyes send discordant signals early in life — because one is misaligned, out of focus, or occluded — the cortex favours the better input and the pathway serving the weaker eye is functionally suppressed. David Hubel and Torsten Wiesel's monocular-deprivation experiments in kittens showed that this competition rewrites the ocular-dominance columns of primary visual cortex, and that the effect is bounded in time. Amblyopia is therefore a cortical disorder of plasticity, not an ocular one. Understanding it clarifies how experience wires the developing brain, why early intervention succeeds where late intervention fails, and how binocular vision is built and lost.

Keywords: amblyopia, critical period, ocular dominance, cortical plasticity, binocular vision

Amblyopia — the lazy eye of common speech — is the most frequent cause of monocular visual impairment in children and young adults, affecting roughly two to four percent of the population (Webber & Wood, 2005). Its defining feature is a paradox: the affected eye is optically and anatomically sound, yet it sees poorly, and no lens can correct the loss. The deficit lives in the brain. During early life the visual cortex depends on balanced, well-focused, concordant input from the two eyes to wire itself correctly; when one eye's input is degraded or when the two eyes disagree, the cortex adapts to the abnormal signal, and that adaptation — not the eye — is what limits vision (Holmes & Clarke, 2006).

The syndrome earned its place in cognitive neuroscience through the Nobel Prize-winning work of Hubel and Wiesel, who used it to expose one of the deepest principles of brain development: that neural circuits are shaped by activity-dependent competition during a bounded critical period (Wiesel & Hubel, 1963). Amblyopia is thus both a clinical condition and a natural experiment in how the developing brain converts visual experience into cortical structure — and in what happens when that experience goes wrong.

What Amblyopia Is

Amblyopia (from Greek *amblys* meaning dull or blunt, and *ops* meaning eye) is a developmental reduction of best-corrected visual acuity in one eye — occasionally both — that cannot be attributed to any structural abnormality of the eye or visual pathway (Von Noorden, 1985). The eye is healthy: its optics are clear, its retina intact, its optic nerve normal. Yet even with the best possible spectacle correction, the eye resolves fine detail poorly. Because nothing in the eye explains the loss, the deficit must lie in how the brain processes that eye's signal — and it does.

The condition arises when, during early development, the visual cortex receives abnormal input from one eye relative to the other. Three circumstances produce this: a misalignment of the eyes (*strabismus*) that sends the cortex two irreconcilable images; a difference in refractive power between the eyes (*anisometropia*) that leaves one image chronically blurred; or a physical obstruction (*deprivation*), such as a congenital cataract or a drooping eyelid, that occludes one eye entirely. In each case the cortex is confronted with a mismatch and adapts by favouring the clearer, better-aligned eye — at the expense of the other (Holmes & Clarke, 2006).

That adaptation is the disorder. The reduced acuity is only its most obvious sign; amblyopia also degrades contrast sensitivity, position discrimination, and — most importantly — binocular function, often abolishing stereopsis, the fine depth perception that requires the two eyes to work together (Levi, 2020). This is why amblyopia is best understood not as a weak eye but as a *cortical* condition in which the neural machinery serving one eye has been outcompeted during a formative window.

Table 1 sets out the three principal forms of amblyopia, the abnormal experience that triggers each, and their shared cortical consequence.

Table 1

The Principal Forms of Amblyopia and Their Triggering Experience

Forms of Amblyopia

The three classical forms of amblyopia are distinguished by the abnormal early experience that causes them, and although they converge on a common cortical endpoint, they differ in mechanism and in the pattern of visual loss they produce (Webber & Wood, 2005).

*Strabismic amblyopia* arises when the eyes are misaligned, so that the two foveae point in different directions. The cortex is presented with two images that cannot be fused into one, and to avoid the double vision (*diplopia*) and confusion this would cause, it suppresses the input from the deviating eye. Sustained suppression during development leaves that eye amblyopic. Strabismic amblyopia characteristically spares low spatial frequencies but severely impairs the accurate localisation of features — a *positional* deficit that goes beyond simple blur (Levi, 2020).

*Anisometropic amblyopia* arises when the two eyes have unequal refractive errors, so that one retina receives a chronically defocused image even when the other is in focus. The cortex favours the sharper image, and the eye supplying the blurred one becomes amblyopic. Because the eyes may remain well aligned, there is no obvious squint to prompt early examination, and anisometropic amblyopia is often discovered only at a school vision screening. Its deficit resembles the effect of chronic blur: contrast sensitivity and acuity fall together, most steeply at high spatial frequencies.

*Deprivation amblyopia* — the form Hubel and Wiesel modelled directly by suturing one eyelid closed in kittens — arises when one eye's image is physically obstructed, most seriously by a congenital cataract. It is the rarest but most severe form, because total deprivation drives the strongest cortical competition against the affected eye, and because the obstruction usually dates from birth, when the cortex is most plastic. Deprivation amblyopia is an ophthalmic emergency: a dense congenital cataract must be removed within the first weeks of life if useful vision is ever to develop in that eye (Birch, 2013).

The Critical Period

The single most important fact about amblyopia is that it can develop only during a bounded window of early life — the critical period (or, more accurately, *sensitive period*) of visual cortical development. Hubel and Wiesel established this directly. Closing one eye of a kitten for a few days early in life produced a profound and largely permanent shift of cortical cells away from the deprived eye; the identical deprivation imposed on an adult cat left cortical responses essentially unchanged (Wiesel & Hubel, 1963). They then mapped the window itself, showing that susceptibility to monocular closure in the kitten rose sharply after the fourth week, peaked around the sixth to eighth week, and declined thereafter (Hubel & Wiesel, 1970).

In humans the corresponding period is longer, spanning roughly the first seven to eight years of life, with the greatest sensitivity in the first two to three years (Daw, 1998). This has two consequences that dominate clinical practice. First, amblyopia is acquired only in childhood: an adult whose eye is occluded or misaligned does not become amblyopic, because the cortex is no longer plastic enough to remodel. Second — and symmetrically — amblyopia is *treatable* only within or near that window, which is why the age at which treatment begins is the strongest predictor of how much vision can be recovered (Holmes et al., 2016).

The critical period is not a passive maturational clock but an actively regulated state. Takao Hensch's work showed that the onset and closure of cortical plasticity are controlled by the maturation of inhibitory (GABAergic) circuits, particular classes of interneuron gating when the cortex will and will not remodel in response to experience (Hensch, 2005). This molecular understanding has reframed the sensitive period as something potentially *reopenable*, and has drawn amblyopia into a broader developmental framework in which multiple sensory and cognitive systems share overlapping, experience-gated windows (Maurer & Hensch, 2012). It is a possibility explored in the Current Directions section below.

The Cortical Basis

Why does abnormal experience in one eye reduce vision through it? The answer lies in the architecture of primary visual cortex (V1) and the principle of activity-dependent competition. In the normal cortex, inputs from the two eyes are segregated into interdigitating ocular-dominance columns — alternating slabs of cortex driven preferentially by the left or the right eye — and most neurons beyond the input layer are *binocular*, driven by both eyes together (Wiesel & Hubel, 1963).

These columns are not fixed at birth; they are sculpted by experience. The two eyes' inputs compete for cortical territory, and the outcome of that competition depends on their relative activity. When both eyes see well, the competition is balanced and the columns are of equal width. When one eye is deprived, its inputs — carrying weak or discordant activity — lose the competition: the deprived eye's columns shrink, the fellow eye's columns expand to fill the vacated territory, and the proportion of cortical neurons that respond to the deprived eye collapses (Hubel & Wiesel, 1970). This is the cortical signature of amblyopia, and it is the reason the eye itself remains normal while vision through it is lost.

Crucially, the competition is *interocular*: it is the imbalance between the eyes, not the absolute deprivation of one, that drives the shift. Closing both eyes produces far less cortical reorganisation than closing one, because with both shut neither eye can win (Wiesel & Hubel, 1963). Animal studies extended these findings from cats to primates, whose visual systems more closely resemble our own, confirming that amblyopia degrades neuronal responses through V1 and into higher extrastriate areas, so that the cortical deficit compounds along the visual hierarchy (Kiorpes, 2006).

Suppression and Binocularity

For much of the twentieth century amblyopia was treated as a monocular problem — a weak eye to be strengthened. The modern view, driven by work on interocular suppression, is that amblyopia is fundamentally a binocular disorder (Hess & Thompson, 2015). The amblyopic cortex does not merely receive a weaker signal from one eye; it actively suppresses that signal whenever the two eyes are open together, to prevent the confusion of rivalrous or mismatched images. This suppression is a major cause of the amblyopic eye's poor acuity: when the fellow eye is covered, the amblyopic eye often performs better than it does under binocular viewing, because the suppression is temporarily lifted.

This reframing has two important implications. First, the loss of stereopsis in amblyopia is not simply a by-product of unequal acuity; it reflects the breakdown of the binocular combination the cortex should perform, and it is often the most functionally significant deficit (Birch, 2013). Second, the deficit is not confined to the amblyopic eye. Karen Meier and Deborah Giaschi's review documented that the fellow eye, long assumed to be normal, in fact shows subtle deficits of its own on demanding tasks, consistent with a disorder of the binocular *system* rather than of one eye alone (Meier & Giaschi, 2017). If suppression is the core pathology, then the logical treatment is not to occlude the good eye but to rebalance the two eyes so the cortex can learn to combine them — the principle behind the binocular therapies now under active trial.

Treatment

The classical treatment for amblyopia is *penalisation of the fellow eye*: forcing the brain to use the amblyopic eye by handicapping the better one. The oldest and most direct method is occlusion — patching the fellow eye for some hours each day — which compels the visual cortex to process the amblyopic eye's input and, within the critical period, drives a partial recovery of its cortical representation (Webber & Wood, 2005). An alternative, pharmacological penalisation, blurs the fellow eye with atropine drops that paralyse its accommodation. The Pediatric Eye Disease Investigator Group's randomised trial established that atropine and patching produce comparable improvements in moderate childhood amblyopia, giving clinicians two effective and interchangeable first-line options (Pediatric Eye Disease Investigator Group, 2002).

Two principles govern the success of penalisation therapy. The first is *timing*: because treatment exploits residual cortical plasticity, it works best in early childhood and its yield declines as the sensitive period closes (Holmes et al., 2016). The second is *the underlying cause*: any optical or obstructive cause must be corrected first — spectacles for anisometropia, surgery for a cataract or a squint — since penalising the fellow eye cannot help if the amblyopic eye still receives a degraded image.

The binocular reframing of amblyopia has generated a newer class of treatment aimed directly at suppression. Rather than occluding the good eye, binocular therapies present each eye with complementary parts of a single image (often through a dichoptic display or video game), with the amblyopic eye's image boosted in contrast, so that the cortex is rewarded for combining the two eyes rather than suppressing one (Hess & Thompson, 2015). Trials of these approaches have been mixed. A randomised comparison found a binocular iPad game no better than standard patching in children (Holmes et al., 2016), and a placebo-controlled trial in older children and adults found only modest benefit from a binocular video game (Gao et al., 2018) — a sobering reminder that a compelling mechanism does not guarantee a superior therapy.

Worked Example

The clinical rule that treatment yield declines with age can be made quantitative with a simple plasticity model. Let the fraction of the acuity deficit that treatment can recover be governed by a residual-plasticity factor that falls with age at treatment following a logistic decline:

$$P(a) = \frac{1}{1 + e^{(a - a_0)/s}}$$

where $a$ is the child's age in years at the start of treatment, $a_0$ is the midpoint of the sensitive-period decline, and $s$ sets how abruptly plasticity falls. Take $a_0 = 6$ years and $s = 1.5$ years, values that place the steep fall in the school-age years. Suppose a child has an amblyopic eye measured at $0.60$ logMAR (about 20/80 on a Snellen chart) and a fellow eye at $0.00$ logMAR (20/20), so the acuity deficit to be recovered is $D = 0.60$ logMAR. The recoverable improvement is $D \times P(a)$, and the residual acuity after treatment is $0.60 - D \times P(a)$.

Consider treatment beginning at age 4:

$$P(4) = \frac{1}{1 + e^{(4 - 6)/1.5}} = \frac{1}{1 + e^{-1.333}} = \frac{1}{1 + 0.264} = 0.79$$

The recoverable improvement is $0.60 \times 0.79 = 0.47$ logMAR, leaving a residual acuity of $0.60 - 0.47 = 0.13$ logMAR — about 20/27, close to normal.

Now begin the identical treatment at age 7:

$$P(7) = \frac{1}{1 + e^{(7 - 6)/1.5}} = \frac{1}{1 + e^{0.667}} = \frac{1}{1 + 1.948} = 0.34$$

The recoverable improvement falls to $0.60 \times 0.34 = 0.20$ logMAR, leaving a residual acuity of $0.40$ logMAR — about 20/50, a marked but incomplete recovery.

Delay to age 10 and $P(10) = 1/(1 + e^{2.667}) = 1/15.39 = 0.065$: the recoverable improvement is just $0.60 \times 0.065 = 0.04$ logMAR, leaving the eye essentially unchanged at $0.56$ logMAR. The same treatment, the same eye, and the same deficit yield a near-complete recovery at age 4, a partial one at age 7, and almost none at age 10. This is the computational face of the sensitive period, and it is why paediatric vision screening aims to detect amblyopia as early as possible — every year of delay moves the child down a steepening curve.

Discussion

Amblyopia occupies a special place in cognitive neuroscience because it was the vehicle for one of the field's foundational discoveries. When Hubel and Wiesel closed one eye of a kitten and found that the cortex reorganised around the imbalance, they demonstrated that neural circuits are not simply wired by a genetic program but are *shaped by experience* during bounded developmental windows — a principle that has since been found to govern the development of language, hearing, and social cognition as well as vision (Wiesel & Hubel, 1963). Amblyopia is the clinical shadow of that principle: the price the visual system pays when the experience it needs to wire itself correctly is disrupted.

The three demonstrations on this page trace the disorder across levels. The critical-period model shows *when* the cortex is vulnerable and treatable; the ocular-dominance demonstration shows the *structural* consequence of imbalanced experience; and the contrast-balance demonstration shows the *perceptual* result — suppression of one eye's contribution — and why rebalancing the eyes is the target of modern therapy. Read together they express a single idea: that vision in each eye is not a property of the eye but an achievement of the cortex, won through balanced binocular experience during development.

The story also carries a cautionary lesson about the gap between mechanism and cure. The binocular account of amblyopia is well supported and has generated elegant, mechanistically motivated treatments — yet the randomised trials of those treatments have so far shown only modest advantage over century-old patching (Holmes et al., 2016; Gao et al., 2018). Understanding a disorder deeply is necessary for treating it well, but, as amblyopia shows, it is not sufficient.

Cognitive Implications

For cognitive psychology, amblyopia is a proof of concept for the *experience-dependence* of perception. It shows that a perceptual ability we take for granted — resolving fine detail with each eye, fusing the two eyes into a single stereoscopic view — is not given but built, and that its construction requires the right input at the right time. The critical-period logic that amblyopia made visible became a template for thinking about all developmental learning: that the brain passes through windows of heightened plasticity during which experience has outsized and lasting effects (Daw, 1998).

Amblyopia also refines the concept of perceptual learning in adults. Although the classical sensitive period closes, the amblyopic visual system retains some capacity for improvement through intensive, structured practice on demanding visual tasks — evidence that plasticity is reduced but not wholly abolished in the mature cortex (Levi & Li, 2009). This bridges amblyopia to the broader study of how training reshapes perception, and it raises the therapeutic question of whether adult plasticity can be recruited to treat a disorder once thought untreatable past childhood.

The deficit is also richer than reduced acuity alone, and this too is instructive. Beyond the loss of resolution, the amblyopic eye shows abnormal *crowding* — a difficulty identifying a target when it is flanked by nearby features that far exceeds the crowding a normal eye shows at matched acuity — along with positional uncertainty and distortions of perceived spatial layout (Levi, 2020). That the deficit extends well past the point of first cortical input, into the mid-level processes that bind and localise features, reinforces the article's central claim: amblyopia is a disorder of cortical visual processing, and reading it as mere blur in one eye understates both the condition and what it reveals about how the visual brain is built.

Finally, amblyopia sharpens the distinction between the eye and the visual brain. Because the amblyopic eye is optically perfect yet functionally impaired, the syndrome forces a clean separation between sensory transduction and cortical processing — a separation that underlies the whole cognitive-neuroscience approach to perception, in which the interesting computations happen not at the receptor but in the cortex that interprets its signals.

Current Directions

Contemporary amblyopia research is organised around one provocative question: can the closed critical period be reopened in the adult brain? Hensch's demonstration that cortical plasticity is gated by the maturation of inhibitory circuitry suggested that manipulating that inhibition — pharmacologically, or through experience — might restore juvenile-like plasticity to the adult cortex (Hensch, 2005). Work on adult human visual cortex has since accumulated evidence that it is more plastic than the classical account allowed, and that interventions ranging from perceptual learning to short-term monocular deprivation and physical exercise can transiently shift the balance between the eyes (Castaldi, Lunghi, & Morrone, 2020).

A second front is the binocular treatment programme. Its mechanistic rationale — that relieving suppression should let the cortex relearn binocular combination — remains compelling, and refinement continues even as the first-generation trials have returned mixed results (Hess & Thompson, 2015; Gao et al., 2018). The open problem is to identify which patients, at which ages, with which forms of amblyopia, stand to gain from binocular versus classical therapy.

The third direction is Dennis Levi's call to *rethink amblyopia* as a disorder of the whole binocular visual system and of higher-level processing, not merely of acuity in one eye (Levi, 2020). On this view the deficits of attention, reading, and visuomotor control that often accompany amblyopia are not incidental but part of the syndrome, and a full treatment must address the system rather than the letter chart. Together these directions are moving amblyopia from a model of *lost* plasticity toward a model of *recoverable* plasticity — with consequences that would reach well beyond the eye.

Common Misconceptions

Amblyopia is a problem with the eye.

No. The amblyopic eye is structurally and optically normal; the deficit lies in the visual cortex, which has adapted to abnormal early input by favouring the other eye. This is why no lens can correct amblyopia and why it is called a cortical disorder (Von Noorden, 1985).

Lazy eye just means a wandering or crossed eye.

No. A visibly misaligned eye is strabismus, which is one *cause* of amblyopia but not the same thing. Amblyopia is the reduced vision itself, and it frequently occurs with perfectly straight eyes, as in the anisometropic form driven by unequal focus (Webber & Wood, 2005).

Children simply grow out of it.

No. Untreated amblyopia persists into adulthood as a permanent visual deficit. It resolves only with treatment, and only treatment begun within or near the sensitive period is reliably effective (Holmes & Clarke, 2006).

Amblyopia only affects the weak eye.

No. Because amblyopia is a disorder of the binocular system, the fellow eye shows subtle deficits of its own, and stereoscopic depth perception — which needs both eyes — is often the most affected function (Meier & Giaschi, 2017).

Glossary

Amblyopia.

A developmental reduction of best-corrected visual acuity in a structurally normal eye, caused by abnormal visual experience during the critical period.

Anisometropia.

A difference in refractive power between the two eyes, leaving one retinal image chronically blurred; a common cause of amblyopia.

Binocular vision.

The cortical combination of the two eyes' images into a single view, the basis of stereopsis and a function amblyopia characteristically disrupts.

Contrast sensitivity.

The ability to detect differences in luminance; reduced in the amblyopic eye, particularly at high spatial frequencies.

Critical period.

A bounded window of early development during which cortical circuits are maximally shaped by experience; also called the sensitive period.

Deprivation amblyopia.

The most severe form, caused by physical obstruction of one eye's image, as by a congenital cataract; a surgical emergency in infancy.

Diplopia.

Double vision; the perception of two images of a single object, which the strabismic cortex avoids by suppressing one eye.

logMAR.

The logarithm of the minimum angle of resolution, a standard acuity scale on which 0.0 equals 20/20 and higher values indicate worse vision.

Occlusion therapy.

Patching the fellow eye to force the cortex to use the amblyopic eye; the classical and still most-used treatment.

Ocular dominance.

The relative influence of each eye on a cortical neuron; in V1 the inputs segregate into ocular-dominance columns whose widths shift with experience.

Penalisation.

Any treatment that handicaps the fellow eye — by patching or by atropine blur — to promote use of the amblyopic eye.

Primary visual cortex (V1).

The first cortical stage of vision, where the eyes' inputs first converge and where the ocular-dominance changes of amblyopia are found.

Stereopsis.

Fine depth perception derived from the small disparity between the two eyes' images; often lost or reduced in amblyopia.

Strabismus.

A misalignment of the eyes so that they point in different directions; a leading cause of amblyopia through interocular suppression.

Suppression.

The active cortical inhibition of one eye's input during binocular viewing; a core mechanism of amblyopia and the target of binocular therapies.

Key Researchers

Eileen E. Birch

Vision scientist at the Retina Foundation of the Southwest and UT Southwestern Medical Center, whose work established the central role of disrupted binocular vision and stereopsis in amblyopia and its treatment. Google Scholar - Faculty Page

Takao K. Hensch

Professor at Harvard University and Boston Children's Hospital who showed that the onset and closure of cortical critical periods are controlled by the maturation of inhibitory circuits, opening the prospect of reopening plasticity. ORCID - Google Scholar - Faculty Page

Robert F. Hess

Director of McGill Vision Research at McGill University, a leading proponent of the view that amblyopia is a binocular disorder of suppression and a developer of binocular approaches to its therapy. Google Scholar - Faculty Page

Jonathan M. Holmes

Chair of Ophthalmology and Vision Science at the University of Arizona and a leader of the Pediatric Eye Disease Investigator Group, whose randomised trials define the evidence base for amblyopia treatment. Faculty Page

David H. Hubel

(1926–2013). Neurophysiologist at Harvard Medical School who, with Torsten Wiesel, mapped the effects of monocular deprivation on the visual cortex, sharing the 1981 Nobel Prize in Physiology or Medicine. Wikipedia - Wikidata

Lynne Kiorpes

Professor of Neural Science at New York University whose primate studies revealed how amblyopia degrades neuronal processing through the visual cortical hierarchy, extending Hubel and Wiesel's findings to systems resembling our own. ORCID - Faculty Page

Dennis M. Levi

Distinguished Professor of Optometry and Vision Science at the University of California, Berkeley, whose work on the perceptual deficits of amblyopia and on perceptual learning has reframed it as a disorder of the whole binocular system. ORCID - Google Scholar - Faculty Page

Torsten N. Wiesel

(born 1924). Neurophysiologist and President Emeritus of The Rockefeller University who, with David Hubel, discovered ocular-dominance plasticity and the visual critical period, sharing the 1981 Nobel Prize in Physiology or Medicine. Wikipedia - Wikidata - Faculty Page

Frequently Asked Questions

What exactly is amblyopia?

Amblyopia, commonly called lazy eye, is reduced vision in an eye that is itself structurally normal. The loss is caused by abnormal visual experience early in life that changes how the visual cortex processes that eye's signal. Because the problem is in the brain, not the eye, glasses alone cannot correct it.

What causes amblyopia?

Three things, all acting in early childhood: a misalignment of the eyes (strabismus), an unequal focus between the eyes (anisometropia), or a physical blockage of one eye such as a cataract (deprivation). Each gives the developing cortex an abnormal or imbalanced input, and the cortex adapts by favouring the better eye.

Is amblyopia the same as a crossed or wandering eye?

No. A visibly turned eye is strabismus, which can cause amblyopia but is not the same condition. Amblyopia is the reduced vision itself, and it often occurs with perfectly straight-looking eyes, especially when the cause is unequal focus between the two eyes.

Why does treatment have to start early?

Because treatment works by exploiting the brain's plasticity, which is greatest in early childhood and declines as the sensitive period closes around age seven or eight. The earlier treatment begins, the more vision can be recovered; delay of even a few years sharply reduces the achievable gain.

How is amblyopia treated?

The standard approach penalises the better eye to force the brain to use the amblyopic one, either by patching it for some hours a day or by blurring it with atropine drops. Any underlying cause, such as a refractive error or a cataract, must be corrected first. Newer binocular treatments aim to relieve suppression instead.

Can adults with amblyopia be helped?

Recovery is harder after the sensitive period closes, but not always impossible. Intensive, structured visual training (perceptual learning) can produce measurable gains in some adults, and research into reopening cortical plasticity is active. Outcomes are more modest and less reliable than treatment in childhood.

Does amblyopia affect depth perception?

Yes, often profoundly. Fine depth perception, or stereopsis, requires the two eyes to work together, and amblyopia disrupts precisely this binocular combination. Loss of stereopsis is frequently the most functionally significant part of the disorder, affecting tasks from threading a needle to judging distances.

Why do cognitive scientists study amblyopia?

Because it was the model system in which Hubel and Wiesel discovered that experience shapes the developing brain during critical periods. Amblyopia shows, in a clean and measurable way, that seeing with each eye is an achievement of the cortex built through early experience, not a fixed property of the eye.

Support Organizations

References